Search Results - "Andrea Marzi"
-
1
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Published in Nature microbiology (01-04-2020)“…Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness…”
Get full text
Journal Article -
2
Marburg virus pathogenesis - differences and similarities in humans and animal models
Published in Virology journal (30-12-2019)“…Marburg virus (MARV) is a highly pathogenic virus associated with severe disease and mortality rates as high as 90%. Outbreaks of MARV are sporadic, deadly,…”
Get full text
Journal Article -
3
Ebola virus disease sequelae and viral persistence in animal models: Implications for the future
Published in PLoS pathogens (01-03-2024)“…Ebola virus disease (EVD), caused by infection with Ebola virus, results in severe, acute illness with a high mortality rate. As the incidence of outbreaks of…”
Get full text
Journal Article -
4
Ebola: Lessons on Vaccine Development
Published in Annual review of microbiology (08-09-2018)“…The West African Ebola virus (EBOV) epidemic has fast-tracked countermeasures for this rare, emerging zoonotic pathogen. Until 2013-2014, most EBOV vaccine…”
Get full text
Journal Article -
5
The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway
Published in PLoS pathogens (16-09-2021)“…Ebola virus (EBOV) expresses three different glycoproteins (GPs) from its GP gene. The primary product, soluble GP (sGP), is secreted in abundance during…”
Get full text
Journal Article -
6
Ebola Virus: Pathogenesis and Countermeasure Development
Published in Annual review of virology (29-09-2019)“…Since its discovery in 1976, Ebola virus (EBOV) has caused numerous outbreaks of fatal hemorrhagic disease in Africa. The biggest outbreak on record is the…”
Get full text
Journal Article -
7
Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses
Published in Emerging infectious diseases (01-02-2015)“…We demonstrated that previous vaccination with a vesicular stomatitis virus (VSV)-based Lassa virus vaccine does not alter protective efficacy of subsequent…”
Get full text
Journal Article -
8
K18-hACE2 mice develop respiratory disease resembling severe COVID-19
Published in PLoS pathogens (19-01-2021)“…SARS-CoV-2 emerged in late 2019 and resulted in the ongoing COVID-19 pandemic. Several animal models have been rapidly developed that recapitulate the…”
Get full text
Journal Article -
9
The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
Published in Human vaccines & immunotherapeutics (02-09-2018)“…The devastating Ebola virus (EBOV) epidemic in West Africa in 2013-2016 accelerated the progress of several vaccines and antivirals through clinical trials,…”
Get full text
Journal Article -
10
Filovirus vaccines as a response paradigm for emerging infectious diseases
Published in npj vaccines (11-10-2024)“…Nowadays, filovirus vaccine development may be seen as a paradigm for our response capabilities to emerging and re-emerging infectious diseases. Specifically,…”
Get full text
Journal Article -
11
A VSV-based Zika virus vaccine protects mice from lethal challenge
Published in Scientific reports (23-07-2018)“…Infection with Zika virus (ZIKV) is commonly mild in humans but has been associated with alarming negative health outcomes including Guillain-Barré syndrome in…”
Get full text
Journal Article -
12
A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection
Published in PLoS neglected tropical diseases (01-09-2020)“…Besides the common Fc receptor (FcR)-mediated mechanism of antibody-dependent enhancement (ADE), Ebola virus (EBOV) is known to utilize the complement…”
Get full text
Journal Article -
13
A fatty acid-ordered plasma membrane environment is critical for Ebola virus matrix protein assembly and budding
Published in Journal of lipid research (01-11-2024)“…Plasma membrane (PM) domains and order phases have been shown to play a key role in the assembly, release, and entry of several lipid-enveloped viruses. In the…”
Get full text
Journal Article -
14
Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates
Published in Proceedings of the National Academy of Sciences - PNAS (29-01-2013)“…Ebola viruses cause hemorrhagic disease in humans and nonhuman primates with high fatality rates. These viruses pose a significant health concern worldwide due…”
Get full text
Journal Article -
15
Lack of protection against ebola virus from chloroquine in mice and hamsters
Published in Emerging infectious diseases (01-06-2015)“…The antimalarial drug chloroquine has been suggested as a treatment for Ebola virus infection. Chloroquine inhibited virus replication in vitro, but only at…”
Get full text
Journal Article -
16
Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain
Published in Emerging infectious diseases (01-10-2015)“…In late 2013, the largest documented outbreak of Ebola hemorrhagic fever started in Guinea and has since spread to neighboring countries, resulting in almost…”
Get full text
Journal Article -
17
An Ebola whole-virus vaccine is protective in nonhuman primates
Published in Science (American Association for the Advancement of Science) (24-04-2015)“…Zaire ebolavirus is the causative agent of the current outbreak of hemorrhagic fever disease in West Africa. Previously, we showed that a whole Ebola virus…”
Get full text
Journal Article -
18
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
Published in mBio (28-05-2019)“…Ebola virus (EBOV) is a single-stranded RNA virus that causes Ebola virus disease (EVD), characterized by excessive inflammation, lymphocyte apoptosis,…”
Get full text
Journal Article -
19
Monoclonal Antibody Cocktail Protects Hamsters From Lethal Marburg Virus Infection
Published in The Journal of infectious diseases (22-11-2018)“…Marburg virus (MARV), family Filoviridae, causes Marburg hemorrhagic fever (MHF) in humans and nonhuman primates with case fatality rates of up to 90%. There…”
Get full text
Journal Article -
20
Development of an Enzyme-Linked Immunosorbent Assay to Determine the Expression Dynamics of Ebola Virus Soluble Glycoprotein during Infection
Published in Microorganisms (Basel) (06-10-2020)“…Ebola virus (EBOV) is a highly pathogenic virus with human case fatality rates of up to 90%. EBOV uses transcriptional editing to express three different…”
Get full text
Journal Article